Explore

Trendline Trendline
Gilead Sciences Acquires Tubulis to Enhance Oncology Pipeline

Gilead Sciences Acquires Tubulis to Enhance Oncology Pipeline

Gilead Sciences Acquires Tubulis to Enhance Oncology Pipeline
Trendline Trendline
CrossBridge Bio Acquired by Eli Lilly to Advance Cancer Treatment Technology

CrossBridge Bio Acquired by Eli Lilly to Advance Cancer Treatment Technology

CrossBridge Bio Acquired by Eli Lilly to Advance Cancer Treatment Technology
Trendline Trendline
Eli Lilly Acquires CrossBridge Bio to Enhance Cancer Treatment with Dual-Payload ADCs

Eli Lilly Acquires CrossBridge Bio to Enhance Cancer Treatment with Dual-Payload ADCs

Eli Lilly Acquires CrossBridge Bio to Enhance Cancer Treatment with Dual-Payload ADCs
Trendline Trendline
Adcendo ApS Secures $75 Million Series C Financing to Advance ADC Cancer Therapies

Adcendo ApS Secures $75 Million Series C Financing to Advance ADC Cancer Therapies

Adcendo ApS Secures $75 Million Series C Financing to Advance ADC Cancer Therapies
Trendline Trendline
Longhorn Vaccines and Diagnostics Unveils Promising Antibody Data for Combating Antimicrobial Resistance

Longhorn Vaccines and Diagnostics Unveils Promising Antibody Data for Combating Antimicrobial Resistance

Longhorn Vaccines and Diagnostics Unveils Promising Antibody Data for Combating Antimicrobial Resistance
Trendline Trendline
Eli Lilly Acquires CrossBridge Bio to Enhance Antibody-Drug Conjugate Development

Eli Lilly Acquires CrossBridge Bio to Enhance Antibody-Drug Conjugate Development

Eli Lilly Acquires CrossBridge Bio to Enhance Antibody-Drug Conjugate Development
Trendline Trendline
Kivu Bioscience to Present Preclinical Data on Next-Generation ADC Programs at AACR Annual Meeting

Kivu Bioscience to Present Preclinical Data on Next-Generation ADC Programs at AACR Annual Meeting

Kivu Bioscience to Present Preclinical Data on Next-Generation ADC Programs at AACR Annual Meeting
SB Nation SB Nation
As it turns out, the ‘power of friendship’ was not enough for Real Madrid vs. Bayern Munich

As it turns out, the ‘power of friendship’ was not enough for Real Madrid vs. Bayern Munich

FC Bayern took down Real Madrid to advance in the UCL.
SB Nation SB Nation
Álvaro Arbeloa: “All Real Madrid’s work went down the drain because of a decision the referee made”

Álvaro Arbeloa: “All Real Madrid’s work went down the drain because of a decision the referee made”

He spoke in Munich after defeat to Bayern
Trendline Trendline
Eli Lilly Acquires CrossBridge Bio to Enhance Cancer Care with $300M Deal

Eli Lilly Acquires CrossBridge Bio to Enhance Cancer Care with $300M Deal

Eli Lilly Acquires CrossBridge Bio to Enhance Cancer Care with $300M Deal
Trendline Trendline
Eli Lilly to Acquire CrossBridge Bio to Enhance Antibody-Drug Conjugate Development

Eli Lilly to Acquire CrossBridge Bio to Enhance Antibody-Drug Conjugate Development

Eli Lilly to Acquire CrossBridge Bio to Enhance Antibody-Drug Conjugate Development
Trendline Trendline
BioNxt Completes GMP Manufacturing for MS Drug, Paving Way for Human Trials

BioNxt Completes GMP Manufacturing for MS Drug, Paving Way for Human Trials

BioNxt Completes GMP Manufacturing for MS Drug, Paving Way for Human Trials